Efficacy and safety of a generic remifentanil formulation versus fentanyl and Ultiva during general anaesthesia: A phase III, prospective, multi-centric, observer-blind, randomised controlled trial

MLA

Indrani Hemantkumar, et al. “Efficacy and Safety of a Generic Remifentanil Formulation versus Fentanyl and Ultiva during General Anaesthesia: A Phase III, Prospective, Multi-Centric, Observer-Blind, Randomised Controlled Trial.” Indian Journal of Anaesthesia, vol. 68, no. 11, Nov. 2024, pp. 985–95. EBSCOhost, https://doi.org/10.4103/ija.ija_289_24.

APA

Indrani Hemantkumar, Ashok Kumar Swain, Manjaree Mishra, Swati Singh, Challakere Lakshminarain Gurudatt, & Janampet Bekkam Giridhar. (2024). Efficacy and safety of a generic remifentanil formulation versus fentanyl and Ultiva during general anaesthesia: A phase III, prospective, multi-centric, observer-blind, randomised controlled trial. Indian Journal of Anaesthesia, 68(11), 985–995. https://doi.org/10.4103/ija.ija_289_24

Chicago

Indrani Hemantkumar, Ashok Kumar Swain, Manjaree Mishra, Swati Singh, Challakere Lakshminarain Gurudatt, and Janampet Bekkam Giridhar. 2024. “Efficacy and Safety of a Generic Remifentanil Formulation versus Fentanyl and Ultiva during General Anaesthesia: A Phase III, Prospective, Multi-Centric, Observer-Blind, Randomised Controlled Trial.” Indian Journal of Anaesthesia 68 (11): 985–95. doi:10.4103/ija.ija_289_24.